iTeos Therapeutics SA, announced that it has been granted EUR 7.5 million in non-dilutive funding to support the clinical development of its lead anti-cancer drug. The funding has been approved on behalf of the Walloon Region by Mr. Jean-Claude Marcourt, Minister for Economy, Industry, Innovation and New technologies.
In a discovery with broad implications for the specialty chemicals industries like pharmaceuticals, researchers at Rice University and the California Institute of Technology have succeeded in a decades-long quest to make left- and right-handed versions of a molecular sieve, one of the most-used industrial, solid materials.
Ensuring safe working conditions for all employees in the biotech industry in Belgium, is the joint ambition of bio.be/essenscia, the federation of Belgian life sciences companies, and the Belgian Biosafety Professionals (BBP), the professional association of experts in biosafety. Both organizations signed a Memorandum of Understanding to collaborate more closely on safety aspects in biotechnology, for employees in both R&D and production.
Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is no longer a death sentence. With the available treatments, an HIV-positive person lives almost as long as someone who is not infected with the virus, on the condition that you daily take virus inhibitors. However, this increases the number of HIV positive people from year to year, which also increases the annual necessary budget for HIV treatment.
iTeos Therapeutics SA, announced that it has been granted EUR 7.5 million in non-dilutive funding to support the clinical development of its lead anti-cancer drug. The funding has been approved on behalf of the Walloon Region by Mr. Jean-Claude Marcourt, Minister for Economy, Industry, Innovation and New technologies.
In a discovery with broad implications for the specialty chemicals industries like pharmaceuticals, researchers at Rice University and the California Institute of Technology have succeeded in a decades-long quest to make left- and right-handed versions of a molecular sieve, one of the most-used industrial, solid materials.
Ensuring safe working conditions for all employees in the biotech industry in Belgium, is the joint ambition of bio.be/essenscia, the federation of Belgian life sciences companies, and the Belgian Biosafety Professionals (BBP), the professional association of experts in biosafety. Both organizations signed a Memorandum of Understanding to collaborate more closely on safety aspects in biotechnology, for employees in both R&D and production.
Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is no longer a death sentence. With the available treatments, an HIV-positive person lives almost as long as someone who is not infected with the virus, on the condition that you daily take virus inhibitors. However, this increases the number of HIV positive people from year to year, which also increases the annual necessary budget for HIV treatment.